Stay updated on Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial

Sign up to get notified when there's something new on the Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.4.1 to v3.4.2. This is a minor metadata update and does not affect the study information.
    Difference
    0.1%
    Check dated 2026-02-13T12:32:17.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page footer shows a revision update, with Revision: v3.4.1 added and Revision: v3.4.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T12:57:57.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a glossary toggle; capitalization tweaks for 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act data'; and updated the page revision to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-29T07:34:06.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. This appears to be an internal version change with no visible impact on study details.
    Difference
    0.1%
    Check dated 2026-01-15T03:11:37.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Locations section now lists study sites by state (Alabama, California, Massachusetts, North Carolina, Ohio, Texas, Washington). The page revision has been updated to v3.3.3 (replacing v3.3.2).
    Difference
    0.8%
    Check dated 2025-12-24T11:33:11.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The Publications section wording was updated to indicate that publications are automatically filled from PubMed and the Revision label changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T13:35:41.000Z thumbnail image

Stay in the know with updates to Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial page.